| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bcaa14f4bd42b39f65055f65ed53281 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2014-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_023d545a210aa989ee381638b7234ecf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b3de5704281dd23cfc5fa4f2a1cd126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f400d703abd60ec98325612509d47db0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95e1207d41f523f618dadc4549b8a96a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72a9319564fc1f8b43a4ca224aa45f30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69d5bb787d9be5002677d6c40cc5ed17 |
| publicationDate |
2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015014820-A1 |
| titleOfInvention |
Prostate cancer immunotherapy |
| abstract |
The present invention relates to a pharmaceutical composition for the immunotherapy of prostate cancer, to the use of peptides for the immunotherapy of prostate cancer and to a peptide that can be used in the context of said immunotherapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017089772-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11779605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11433099-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020127546-A3 |
| priorityDate |
2013-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |